| P50 | author | Peter D Burbelo | Q90463908 |
| | Niki Moutsopoulos | Q91955673 |
| | Sergio D Rosenzweig | Q98566586 |
| | Martha Quezado | Q110348734 |
| | David E. Kleiner | Q41449492 |
| | Heidi H. Kong | Q42556182 |
| | Chyi-Chia R Lee | Q55692064 |
| | Gulbu Uzel | Q89553717 |
| P2093 | author name string | Jeffrey B Kopp | |
| | Steven M Holland | |
| | Kenneth N Olivier | |
| | Amanda L Collar | |
| | Amy P Hsu | |
| | Elise M N Ferre | |
| | Lynne Yockey | |
| | Michail S Lionakis | |
| | Muthulekha Swamydas | |
| | Stacey R Rose | |
| | Theo Heller | |
| | Kelly D Stone | |
| | Sally Hunsberger | |
| | Ilias Alevizos | |
| | Timothy J Break | |
| | David M Lang | |
| | Katherine R Calvo | |
| | Mukil Natarajan | |
| | Wenjuan Gu | |
| | Lindsey B Rosen | |
| | Sarah K Browne | |
| | Thomas A Fleisher | |
| | Jennifer Adjemian | |
| | Ariane Soldatos | |
| | Julie E Niemela | |
| | Cathleen Frein | |
| | Karen K Winer | |
| | Rachel J Bishop | |
| | Angela Pham | |
| | David Chascsa | |
| | Joseph Monsale | |
| | Shakuntala Rampertaap | |
| | Anamaria Bondici | |
| | Thomas Simcox | |
| | Kimberly R Romito | |
| | Morgan N Similuk | |
| P2860 | cites work | Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen | Q24647314 |
| | A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins | Q24813048 |
| | Dominant Mutations in the Autoimmune Regulator AIRE Are Associated with Common Organ-Specific Autoimmune Diseases | Q28116288 |
| | Projection of an immunological self shadow within the thymus by the aire protein | Q28207164 |
| | Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4 | Q28247732 |
| | Mutation analyses of North American APS-1 patients | Q28293798 |
| | Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1 | Q28768582 |
| | Identification of tryptophan hydroxylase as an intestinal autoantigen | Q32045209 |
| | Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia | Q33346691 |
| | Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines | Q33348588 |
| | Polyglandular autoimmune syndrome type I among Iranian Jews | Q33594705 |
| | Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I | Q33656182 |
| | Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease | Q33908179 |
| | 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease | Q33969697 |
| | Two major autoantibody clusters in systemic lupus erythematosus | Q34171558 |
| | Rapid induction of autoantibodies during ARDS and septic shock | Q34267557 |
| | A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1 | Q34388164 |
| | Extrapancreatic autoantibody profiles in type I diabetes | Q34428374 |
| | Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group | Q34523084 |
| | Organ-specific innate immune responses in a mouse model of invasive candidiasis | Q34769434 |
| | Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. | Q34936576 |
| | Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. | Q34977002 |
| | A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice | Q35153782 |
| | Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c⁺ B-cell population is important for the development of autoimmunity | Q35153786 |
| | Antibody profiling by Luciferase Immunoprecipitation Systems (LIPS) | Q35187324 |
| | Polyglandular autoimmune syndrome type I - a novel AIRE mutation in a North American patient | Q35531540 |
| | CD11c-Expressing B Cells Are Located at the T Cell/B Cell Border in Spleen and Are Potent APCs | Q35762700 |
| | Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia | Q35876586 |
| | Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones | Q36026609 |
| | Immunophenotypic characterisation of peripheral blood lymphocytes in autoimmune polyglandular syndrome type 1: clinical study and review of the literature | Q36063773 |
| | Antibody-profiling technologies for studying humoral responses to infectious agents | Q36160093 |
| | Mechanisms of an autoimmunity syndrome in mice caused by a dominant mutation in Aire | Q36540892 |
| | A new luminescence assay for autoantibodies to mammalian cell-prepared insulinoma-associated protein 2. | Q36842064 |
| | A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1. | Q37147503 |
| | Aire | Q37419376 |
| | BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease | Q37438932 |
| | Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED)--a diagnostic and therapeutic challenge. | Q37684783 |
| | Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: report of seven additional sicilian patients and overview of the overall series from sicily. | Q38233555 |
| | Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy | Q38542575 |
| | Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. | Q39109898 |
| | Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. | Q40479586 |
| | Autoimmune polyendocrine syndrome type 1 (APS I) in Norway | Q44931576 |
| | Determination of human anticytokine autoantibody profiles using a particle-based approach. | Q50520646 |
| | Immunological findings in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and their family members: are heterozygotes subclinically affected? | Q50761662 |
| | Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients. | Q51359287 |
| | Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in the Irish population. | Q51770590 |
| | The EUROclass trial: defining subgroups in common variable immunodeficiency. | Q51971194 |
| | A new CD21low B cell population in the peripheral blood of patients with SLE. | Q51997566 |
| | Frequent occurrence of asplenism and cholelithiasis in patients with autoimmune polyglandular disease type I | Q52234986 |
| | A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. | Q55035365 |
| | Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. | Q55042744 |
| | Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I. | Q55052934 |
| | Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. | Q55057090 |
| | AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I | Q57506468 |
| | Autoimmune Regulator-1 Messenger Ribonucleic Acid Analysis in a Novel Intronic Mutation and Two Additional NovelAIREGene Mutations in a Cohort of Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Patients | Q57715664 |
| | Molecular background of polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome in a Polish population: novel AIRE mutations and an estimate of disease prevalence | Q59697428 |
| | Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab | Q61960512 |
| | Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay | Q73320124 |
| | Effect of anti-thyroid peroxidase (TPO) antibodies on TPO activity measured by chemiluminescence assay | Q73615786 |
| | Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus | Q77734820 |
| | Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease | Q81125373 |
| | Autoimmune polyglandular syndrome type 1 in Russian patients: clinical variants and autoimmune regulator mutations | Q84082628 |
| P433 | issue | 13 | |
| P921 | main subject | candidiasis | Q273510 |
| | diagnosis | Q16644043 |
| P577 | publication date | 2016-08-01 | |
| P1433 | published in | JCI insight | Q27727187 |
| P1476 | title | Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy | |
| P478 | volume | 1 | |